Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-23-000164

Options or other derivatives

  • Chief Commercial Officer acquired 1,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Robert Paul JR Chief Commercial Officer 2023-12-04 Grant or award · Stock Option (Right to Buy) +1,500,000 1,500,000 D
Loading xslF345X05/wk-form4_1701814328.xml…